TauRx Pharmaceuticals is claiming an Alzheimer’s win despite admitting that the study’s placebo blinding broke — and that a valid placebo-controlled trial is impossible with the drug, hydromethylthionine mesylate (HMTM).
Source: Drug Industry Daily